Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6383135 | 7135602 | I | 6383135-6 | 20090916 | 20090917 | 20090930 | EXP | CN-GENENTECH-290865 | GNEFDAAERSPRD | 55 | M | Y | 20090930 | CN | UNITED KINGDOM |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 6383135 | 1012357326 | PS | BEVACIZUMAB | 2 | 330 MG, Q2W | B3364 | |||||
| 6383135 | 1012357327 | C | NEXIUM | 1 | UNK | ||||||
| 6383135 | 1012357328 | C | DICLOFENSINE | 2 | UNK |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 6383135 | 1012357326 | HEPATIC NEOPLASM MALIGNANT |
| 6383135 | 1012357327 | DRUG USE FOR UNKNOWN INDICATION |
| 6383135 | 1012357328 | DRUG USE FOR UNKNOWN INDICATION |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 6383135 | LT |
Reactions reported
| Event ID | PT |
|---|---|
| 6383135 | LIVER CARCINOMA RUPTURED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 6383135 | 1012357326 | 20090916 | 20090917 | 2 | DAY |
| 6383135 | 1012357327 | 20090916 | 20090917 | 2 | DAY |
| 6383135 | 1012357328 | 20090916 | 20090917 | 2 | DAY |